Yahoo Finance

Alethia Biotherapeutics Announces the Issuance of a Patent for the Use of Anti-Siglec-15 Antibodies

MONTREAL, QUEBEC--(Marketwired - Oct 9, 2013) - Alethia Biotherapeutics Inc., a privately held biotechnology company, announced today that a "composition of matter" patent no. 8,540,988 entitled ...
Yahoo Finance

Alethia Biotherapeutics Announces Entry into Licensing and Research Agreements for its Inhibitor of EMT with IBC Generium

MONTREAL, CANADA and MOSCOW, RUSSIA--(Marketwired - May 29, 2013) - Alethia Biotherapeutics Inc., a privately held biotechnology company focused on developing therapeutic monoclonal antibodies (mAb), ...
FierceBiotech

Alethia Biotherapeutics Closes a $4.7 Million Financing to Advance its Bone Antiresorptive Program

MONTREAL, QUEBEC--(Marketwire - Nov. 1, 2012) - Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies announced today ...
FierceBiotech

Alethia Biotherapeutics Secures C$9.6 Million in Series A Financing to Fund Its Therapeutic Monoclonal Antibody Product Pipeline

Alethia Biotherapeutics Secures C$9.6 Million in Series A Financing to Fund Its Therapeutic Monoclonal Antibody Product Pipeline MONTREAL, QUEBEC--(Marketwire - Sept. 7, 2010) - Alethia ...
Los Angeles Business Journal

Alethia Raises $50 Million With a Beverage Focus

Yet another investment vehicle geared towards the trendy food and beverage sector has launched in Los Angeles. Brentwood-based Alethia Venture Partners announced on Oct. 12 its $50 million debut fund, ...
Yahoo

Alethia Biotherapeutics Closes a $4.7 Million Financing to Advance its Bone Antiresorptive Program

MONTREAL, QUEBEC--(Marketwire - Nov 1, 2012) - Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies announced today ...